In the News | Friends of Cancer Research

You are here

In the News

March 19, 2020
Industry experts told AgencyIQ that ongoing clinical trials, as well as trials that were set to begin enrollment, could be hit hard by ripple effects from the novel coronavirus outbreak. Both... Read more
March 19, 2020
For about 20 minutes on Thursday, President Trump undermined six decades of dogma on the development of safe and effective drugs.   Trump, addressing a nation under shelter and quarantine from the... Read more
March 18, 2020
Like millions of our colleagues, friends, and family, Friends of Cancer Research is adjusting to the rapidly changing public health crisis being caused by COVID-19 (Novel Coronavirus). We are... Read more
March 6, 2020
Friends of Cancer Research (Friends) would like to thank Senators Burr and Bennet and Representatives DeGette and Bucshon for their commitment to patients through the introduction of the Verifying... Read more
March 3, 2020
There are multiple reasons why the majority of breast cancer patients do not participate in clinical trials. One reason often emphasized is that patients simply decide not to participate when asked... Read more
March 2, 2020
We’ve been talking about the value of real-world evidence (RWE) for years. A myriad of new data sources is being developed and linked, and a core set of analytic tools are coming into use. We now see... Read more
February 26, 2020
Federal regulatory agencies can’t stand still. They must evolve with industries they regulate.   No agency faces more pressure to do this than the Food and Drug Administration. Charged with... Read more
February 25, 2020
A team of leaders in patient advocacy and education at the Black Women’s Health Imperative, Friends of Cancer Research (Friends), and Stand Up To Cancer (SU2C) have been approved for a funding award... Read more
February 25, 2020
Executive Summary Rutgers University professor testifies in support of bill directing the FDA to designate National Centers of Excellence in Continuous Manufacturing; other bills target generic... Read more
February 21, 2020
This is a formidable challenge. Cancer trials were, and remain, notoriously time-consuming to launch, expensive to run, and difficult to enroll patients to. A deeper understanding of cancer biology... Read more

Pages